Match!

AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

Published on Feb 28, 2019in Bioscience Reports2.535
· DOI :10.1042/BSR20181995
Qingguo Lu3
Estimated H-index: 3
(Sichuan University),
Xuan Li3
Estimated H-index: 3
(UMMC: University of Mississippi Medical Center)
+ 5 AuthorsJi Li34
Estimated H-index: 34
(UMMC: University of Mississippi Medical Center)
Abstract
Diabetics have higher morbidity and mortality in cardiovascular disease (CVD). A variety of antidiabetic agents are available for clinical choice. Cardiovascular (CV) safety assessment of these agents is crucial in addition to hypoglycemic effect before clinical prescription. Adenosine 5′-monophosphate-activated protein kinase (AMPK) is an important cell energy sensor, which plays an important role in regulating myocardial energy metabolism, reducing ischemia and ischemia/reperfusion (I/R) injury, improving heart failure (HF) and ventricular remodeling, ameliorating vascular endothelial dysfunction, antichronic inflammation, anti-apoptosis, and regulating autophagy. In this review, we summarized the effects of antidiabetic agents to CVD according to basic and clinical research evidence and put emphasis on whether these agents can play roles in CV system through AMPK-dependent signaling pathways. Metformin has displayed definite CV benefits related to AMPK. Sodium-glucose cotransporter 2 inhibitors also demonstrate sufficient clinical evidence for CV protection, but the mechanisms need further exploration. Glucagon-likepeptide1 analogs, dipeptidyl peptidase-4 inhibitors, α-glucosidase inhibitors and thiazolidinediones also show some AMPK-dependent CV benefits. Sulfonylureas and meglitinides may be unfavorable to CV system. AMPK is becoming a promising target for the treatment of diabetes, metabolic syndrome and CVD. But there are still some questions to be answered.
  • References (172)
  • Citations (3)
📖 Papers frequently viewed together
11 Citations
4 Citations
792 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References172
Newest
#1Nouf T. Al-Damry (KSU: King Saud University)H-Index: 1
#2Hala A. Attia (KSU: King Saud University)H-Index: 6
Last. Muhammad Atteya (KSU: King Saud University)H-Index: 4
view all 8 authors...
Abstract The present study aimed to investigate the protective effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on diabetic cardiomyopathy (DCM)-associated apoptosis and if this effect is mediated via modulating the activity of the survival kinases; AMP-activated protein kinase (AMPK) and Akt & the apoptotic kinases; glycogen synthase kinase-3 β (GSK-3β) and p38 mitogen-activated protein kinase (p38MAPK). Diabetes was induced by a single intraperitoneal injection of streptozotocin (55 ...
1 CitationsSource
#1Araz Rawshani (University of Gothenburg)H-Index: 14
#2Naveed Sattar (Glas.: University of Glasgow)H-Index: 119
Last. Soffia Gudbjörnsdottir (Glas.: University of Glasgow)H-Index: 40
view all 8 authors...
Summary Background People with type 1 diabetes are at elevated risk of mortality and cardiovascular disease, yet current guidelines do not consider age of onset as an important risk stratifier. We aimed to examine how age at diagnosis of type 1 diabetes relates to excess mortality and cardiovascular risk. Methods We did a nationwide, register-based cohort study of individuals with type 1 diabetes in the Swedish National Diabetes Register and matched controls from the general population. We inclu...
46 CitationsSource
#1Xu Chen (UMMC: University of Mississippi Medical Center)H-Index: 6
#2Xuan Li (UMMC: University of Mississippi Medical Center)H-Index: 3
Last. Ji Li (UMMC: University of Mississippi Medical Center)H-Index: 34
view all 10 authors...
Abstract Background AMP-activated Protein Kinase (AMPK) is a stress-activated kinase that protects against cardiomyocyte injury during ischemia and reperfusion. c-Jun N-terminal kinase (JNK), a mitogen activated protein kinase, is activated by ischemia and reperfusion. NF-κB is an important transcription factor involved in ischemia and reperfusion injury. Methods and Results The intrinsic activation of AMPK attenuates the inflammation which occurred during ischemia/reperfusion through the modula...
21 CitationsSource
#1Hao Zhou (Chinese PLA General Hospital)H-Index: 20
#2Shuyi Wang (College of Health Sciences, Bahrain)H-Index: 3
Last. Jun Ren (Fudan University)H-Index: 71
view all 6 authors...
Abstract Impaired cardiac microvascular function contributes to diabetic cardiovascular complications although effective therapy remains elusive. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor recently approved for treatment of type 2 diabetes, promotes glycosuria excretion and offers cardioprotective actions beyond its glucose-lowering effects. This study was designed to evaluate the effect of empagliflozin on cardiac microvascular injury in diabetes and the underlying mechan...
74 CitationsSource
#1Feng Gao (Peking Union Medical College)H-Index: 1
#2Jie-Mei Chen (Peking Union Medical College)H-Index: 1
Last. Haibo Zhu (Peking Union Medical College)H-Index: 2
view all 3 authors...
Endothelial dysfunction is caused by many factors, such as dyslipidemia, endoplasmic reticulum (ER) stress, and inflammation. It has been demonstrated that endothelial dysfunction is the initial process of atherosclerosis. AMP-activated protein kinase (AMPK) is an important metabolic switch that plays a crucial role in lipid metabolism and inflammation. However, recent evidence indicates that AMPK could be a target for atherosclerosis by improving endothelial function. For instance, activation o...
4 CitationsSource
#1Raja Gopoju (Indian Institute of Chemical Technology)H-Index: 4
#2Sravya Panangipalli (Indian Institute of Chemical Technology)H-Index: 1
Last. Srigiridhar Kotamraju (Indian Institute of Chemical Technology)H-Index: 28
view all 3 authors...
Abstract Lipids are responsible for the atheromatous plaque formation during atherosclerosis by their deposition in the subendothelial intima of the aorta, leading to infarction. Sterol regulatory element-binding protein 2 (SREBP2), regulating cholesterol homeostasis, is suggested to play a pivotal role during the early incidence of atherosclerosis through dysregulation of lipid homeostasis. Here we demonstrate that oxidative stress stimulates SREBP2-mediated cholesterol uptake via low density l...
5 CitationsSource
#1Sarah J. Mancini (Glas.: University of Glasgow)H-Index: 6
#2Daria Boyd (Glas.: University of Glasgow)H-Index: 1
Last. Ian P. Salt (Glas.: University of Glasgow)H-Index: 28
view all 8 authors...
Recent clinical trials of the hypoglycaemic sodium-glucose co-transporter-2 (SGLT2) inhibitors, which inhibit renal glucose reabsorption, have reported beneficial cardiovascular outcomes. Whether SGLT2 inhibitors directly affect cardiovascular tissues, however, remains unclear. We have previously reported that the SGLT2 inhibitor canagliflozin activates AMP-activated protein kinase (AMPK) in immortalised cell lines and murine hepatocytes. As AMPK has anti-inflammatory actions in vascular cells, ...
21 CitationsSource
#1Leon Varjabedian (Carilion Roanoke Memorial Hospital)H-Index: 3
#2Mohammad Bourji (UB: University at Buffalo)H-Index: 1
Last. Nader D. Nader (UB: University at Buffalo)H-Index: 23
view all 4 authors...
Metformin is a biguanide that is widely used as an insulin-sparing agent to treat diabetes. When compared with the general population, diabetics are twice as likely to die from fatal myocardial infarction and congestive heart failure (CHF). There has been a significant concern regarding the use of metformin in patients with CHF because of their higher tendency to develop lactic acidosis. However, large epidemiological trials have reported better cardiovascular prognosis with metformin compared t...
15 CitationsSource
#1Takehiko Sambe (Brigham and Women's Hospital)H-Index: 1
#2R. Preston Mason (Brigham and Women's Hospital)H-Index: 31
Last. Tadeusz Malinski (OU: Ohio University)H-Index: 45
view all 5 authors...
Abstract Reduction of nitric oxide (NO), a potent vasodilator, and an increase in cytotoxic peroxynitrite (ONOO − ) may be associated with the uncoupling of NO synthase (eNOS) and endothelial cell (EC) dysfunction. In addition to its effect on glucose control, metformin, may also directly benefit in the restoration of the function of eNOS and EC. Obese Zucker rats were administered vehicle or 300 mg/kg/day metformin for 4 weeks. NO concentration [NO] and ONOO − concentration [ONOO − ] were measu...
7 CitationsSource
#1Kyung Young Lee (Yeungnam University)H-Index: 4
#2Jae-Ryong Kim (Yeungnam University)H-Index: 28
Last. Hyoung Chul Choi (Yeungnam University)H-Index: 16
view all 3 authors...
Abstract Gliclazide, a sulfonylurea that is widely used to treat type II-diabetes, specifically blocks KATP channels and recombinant smooth muscle (SUR2B/Kir6.1) KATP channels with high potency. Furthermore, it exerts antioxidant properties and inhibits tumor cell proliferation. In this study, we investigated the inhibitory effect of gliclazide on vascular smooth muscle cell (VSMC) proliferation and tried to identify the underlying signaling pathway. We first investigated the effect of gliclazid...
3 CitationsSource
Cited By3
Newest
#1Chintan N. KoyaniH-Index: 1
#1Chintan N. Koyani (Medical University of Graz)H-Index: 9
Last. Dirk von LewinskiH-Index: 17
view all 10 authors...
Abstract Aims Sodium-glucose co-transporter 2 (SGLT2) were originally developed as kidney-targeting anti-diabetic drugs. However, due to their beneficial cardiac off-target effects (as SGLT2 is not expressed in the heart), these antagonists currently receive intense clinical interest in the context of heart failure (HF) in patients with or without diabetes mellitus (DM). Since the mechanisms by which these beneficial effects are mediated are still unclear yet, inflammation that is present in DM ...
Source
#1Mette E Bornstedt (Oslo University Hospital)
#1Mette E. Bornstedt (University of Oslo)H-Index: 2
Last. Per Medbøe Thorsby (Oslo University Hospital)H-Index: 13
view all 6 authors...
BACKGROUND: Studies have shown that vitamin D can enhance glucose-stimulated insulin secretion (GSIS) and change the expression of genes in pancreatic beta-cells. Still the mechanisms linking vitamin D and GSIS are unknown. MATERIAL AND METHODS: We used an established beta-cell line, INS1E. INS1E cells were pre-treated with 10 nM 1,25(OH)2vitamin D or 10 nM 25(OH)vitamin D for 72 hours and stimulated with 22 mM glucose for 60 minutes. RNA was extracted for gene expression analysis. RESULTS: Expr...
Source
Purpose To explore the molecular mechanism of glycine in improving ischemic stroke. Patients and Methods The serum samples of patients with ischemic stroke and healthy people were compared. The ischemic stroke model of PC12 cells was established by oxygen-glucose deprivation (OGD). qPCR quantified miR-19a-3p and AMPK mRNA, and protein expression was detected by Western blot. MTT was used to detect cell activity. Flow cytometry was used to detect cells. Glucose metabolism kit was used to detect g...
Source
#1Nehal S. Wahba (Zagazig University)
#2Rasha H. Abdelghany (Zagazig University)H-Index: 5
Last. Amira Ebrahim Alsemeh (Zagazig University)H-Index: 1
view all 5 authors...
Abstract Insulin resistance (IR) seemingly play a role in chronic kidney disease (CKD). The present study has elucidated the crucial interplay of oxidative stress, inflammatory, apoptotic and profibrotic signaling pathways linking IR to CKD. The study aimed at investigating the pleiotropic nephroprotective effects of either vildagliptin or vitamin D3 in a fructose/salt-induced IR rat model, highlighting the potential molecular mechanisms underlying their action. Another interesting target was to...
Source
#1Rachel Njeim (AUB: American University of Beirut)
#2Theresa Farhat (AUB: American University of Beirut)H-Index: 2
Last. Assaad A. Eid (AUB: American University of Beirut)H-Index: 16
view all 9 authors...
Diabetic kidney disease is one of the most serious complications of diabetes worldwide and is the leading cause of end-stage renal disease. While research has primarily focused on hyperglycemia as a key player in the pathophysiology of diabetic complications, recently, increasing evidence have underlined the role of adipose inflammation in modulating the development and/or progression of diabetic kidney disease. This review focuses on how adipose inflammation contribute to diabetic kidney diseas...
1 CitationsSource
Doxorubicin is a commonly used chemotherapeutic agent for the treatment of a range of cancers, but despite its success in improving cancer survival rates, doxorubicin is cardiotoxic and can lead to congestive heart failure. Therapeutic options for this patient group are limited to standard heart failure medications with the only drug specific for doxorubicin cardiotoxicity to reach FDA approval being dexrazoxane, an iron-chelating agent targeting oxidative stress. However, dexrazoxane has failed...
2 CitationsSource
#1Hong Wei (HMU: Harbin Medical University)H-Index: 1
#2Rui Bu (HMU: Harbin Medical University)H-Index: 1
Last. Yanjun Chen (PKU: Peking University)
view all 7 authors...
Diabetic cardiomyopathy is a common cardiac condition in patients with diabetes mellitus, which results in cardiac hypertrophy and subsequent heart failure. Chronic inflammation in the diabetic heart results in loss of cardiomyocytes and subsequentially cardiac dysfunction. Accumulated evidence implicated pyroptosis as a vital contributor to the hyperglycemia-induced cardiac inflammatory response. Exendin-4, a GLP analog, promotes survival of cardiomyocytes in cardiovascular diseases, including ...
Source
#1Mariam Gamal Fahmy Wahba (Nahda University)H-Index: 1
#2Basim Anwar Shehata Messiha (Beni-Suef University)H-Index: 8
Last. Ali Ahmed Abo-Saif (Nahda University)H-Index: 4
view all 4 authors...
Abstract Endothelial dysfunction and vascular reactivity defects secondary to metabolic and immunological disorders carry risk of serious cardiovascular complications. Here, the effects of the phosphodiesterase (PDE) inhibitors vardenafil and cilostazol were examined against rheumatoid arthritis (RA)/diabetes mellitus (DM)-co-morbidity-induced endothelial dysfunction and vascular reactivity defects. After setting of RA/DM-co-morbidity model, rats were divided into a normal control group, an RA/D...
Source
#1Yasmin Moustafa Ahmed (Nahda University)H-Index: 2
#2Basim Anwar Shehata Messiha (Beni-Suef University)H-Index: 8
Last. Ali Ahmed Abo-Saif (Nahda University)H-Index: 4
view all 4 authors...
Abstract Background In the current investigation, the effects of the P2Y12 blocker ticagrelor, the sodium/glucose transporter-2-inhibitor empagliflozin, and the selective estrogen receptor modulator tamoxifen were examined against rheumatoid arthritis (RA)/ diabetes mellitus (DM)-co-morbidity-induced defects in vascular reactivity. Methods After model setting, rats were allocated into a normal control, an RA/DM-co-morbidity, and three treatment groups receiving ticagrelor, empagliflozin and tamo...
Source
The metabolic rewiring of tumor cells and immune cells has been viewed as a promising source of novel drug targets. Many of the molecular pathways implicated in rheumatoid arthritis (RA) directly modify synovium metabolism and transform the resident cells, such as the fibroblast-like synoviocytes (FLS), and the synovial tissue macrophages (STM), toward an overproduction of enzymes, which degrade cartilage and bone, and cytokines, which promote immune cell infiltration. Recent studies have shown ...
Source